CytoDyn Inc.
OTC:CYDY
Overview | Financials
Company Name | CytoDyn Inc. |
Symbol | CYDY |
Currency | USD |
Price | 0.18 |
Market Cap | 167,607,360 |
Dividend Yield | 0% |
52-week-range | 0.15 - 0.48 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Antonio Migliarese CPA |
Website | https://www.cytodyn.com |
An error occurred while fetching data.
About CytoDyn Inc.
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as coronavirus disease (COVID-19). It is
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD